NCT00601263View on ClinicalTrials.gov

Safety Study of Chinese Herbal Therapy to Treat Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Asthma
Interventions
DRUG

Anti-Asthma Herbal Medical Intervention (ASHMI)

We propose to test 3 daily doses in which 2,4, or 6 ASHMI or placebo capsules will be administered orally twice daily (BID) for 7 days.

Trial Locations (1)

10029

Mount Sinai School Medicine, New York

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Xiu-Min Li

OTHER

NCT00601263 - Safety Study of Chinese Herbal Therapy to Treat Asthma | Biotech Hunter | Biotech Hunter